Phase I/Ii Study of Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Patients Treated by Chemotherapy (Ice) in Second Line Before Autologous Transplantation.
Hematological Oncology - United Kingdom
doi 10.1002/hon.2440_6
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley